CTI BioPharma Corp.

02/14/2018 | Press release | Distributed by Public on 02/14/2018 15:18

CTI BioPharma to Present at the 7th Annual Leerink Partners Global Healthcare Conference

SEATTLE, Feb. 14, 2018 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management will present at the 7th Annual Leerink Partners Global Healthcare Conference in New York, NY on Thursday, February 15, 2018 at 2:30 PM ET and host one-on-one meetings.

The presentation will be webcast live and available for replay from the Investors section of CTI BioPharma's website at

About CTI BioPharma Corp.

CTI BioPharma Corp. is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers that offer a unique benefit to patients and healthcare providers. CTI BioPharma has a late-stage development pipeline, including pacritinib for the treatment of patients with myelofibrosis. CTI BioPharma is headquartered in Seattle, Washington. For additional information and to sign up for email alerts and get RSS feeds, please visit

CTI BioPharma Investor Contacts:
Tricia Truehart
+1 646 378 2953
[email protected]

View original content with multimedia:

SOURCE CTI BioPharma Corp.